The Weekly Roundup: March 16-20

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Recognizing the Right Time to Start Biologics in HS

Experts discuss how clinicians identify the right moment to transition from conventional therapy to biologic treatment in patients with hidradenitis suppurativa (HS).

Rethinking Severity Assessment in Alopecia Areata

Experts discuss why alopecia areata should be viewed as a systemic condition with psychosocial consequences beyond visible hair loss.

Redefining Treatment Success in the Modern Psoriasis Era

Chovatiya discusses treat-to-target goals, biologics, BSA remission, and patient burden in psoriasis.

Phase 3 ADorable-1 Data Support Lebrikizumab for Children With AD

Positive phase 3 findings from ADorable-1 suggest lebrikizumab could expand biologic treatment options for younger patients with atopic dermatitis (AD).

Tildrakizumab Moves Toward New Indication with sBLA Acceptance for Active Psoriatic Arthritis

Sun Pharmaceuticals’ tildrakizumab nears PsA approval as FDA accepts a supplemental Biologics License Application, spotlighting IL-23 benefits for active disease.

New Review Quantifies the Sexual Health Burden in Patients with Asthma and Atopic Dermatitis

Meta-analysis finds sexual dysfunction common in asthma and AD, with rates hitting 54% in asthma, prompting better screening.

Head-to-Head PsA Trial Data May Inform Skin-Joint Treatment Decisions

New top-line results from the BE BOLD trial provide dermatology clinicians with comparative data on 2 biologic therapies targeting different inflammatory pathways in psoriatic arthritis (PsA).

Earlier Biologic Intervention Is Necessary in Moderate to Severe Hidradenitis Suppurativa

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, reviewed clinical trial and long-term data supporting biologic use in HS and discussed practical considerations for patient selection, timing, and durability of response.

Perimenopause Is in My Derm Rooms Now, and It Matters

Women often present with sudden skin, hair, and vascular changes that may signal perimenopause rather than normal aging.

Physician-Led Dermatology: Why Building Your Own Practice Still Matters

Discover how physician-led dermatology practices build patient-first culture, drive innovation, and sustain long-term care in a changing health care market.

NEA Data Highlight Persistent Access Issues in Eczema

New data show that nearly 40% of eczema patients face insurance-related barriers, delaying or preventing access to prescribed therapies.

Investigating the Roles of SAA1, Insulin, and Lipid Profiles in Acne Pathogenesis and Severity

New study links acne to higher serum amyloid A1 inflammation, while lipid shifts hint at systemic effects and new clues for scars and severity.

Journal Digest: March 18, 2026

This review of the latest dermatological studies includes insights on chronic hand eczema patch testing, case reporting, microbiome impact, and more.

FDA Approves Icotrokinra, First Oral IL-23 Receptor Blocker for Psoriasis

Clinical trial data showed approximately 70% of patients achieved clear or almost clear skin with icotrokinra by week 16.

Scratch That: A Dermatologist’s Guide to Battling Burnout

Defined by emotional exhaustion, depersonalization, and reduced accomplishment, burnout goes beyond a difficult day in clinic.

Dermatology Trainees Embrace AI—With Reservations

Trainees identified legal, ethical, and reliability concerns as key barriers to integrating AI into dermatology practice.

Addressing Adherence: Supporting Patients With Psoriasis

Noor discussed strategies to improve psoriasis care for patients facing adherence challenges related to lifestyle or cognitive barriers.

Molecular Classifiers Outperform Histopathology in Challenging Psoriasis and Eczema Cases

Molecular NOS2/CCL27 testing outperforms standard biopsy reads for psoriasis versus eczema, reducing diagnostic uncertainty in CHE and speeding targeted treatment.

FAQtual Insights: The Contract Playbook Part 1

Clinician contract negotiation is often treated as administrative, but it directly affects pay, autonomy, workflow, and career trajectory.

DermGPT: Beyond AI Search in Dermatology

When used thoughtfully, AI transforms generic processes into innovative, time-saving clinical tools.

Understanding Aging Hair

Aging hair fibers become finer in diameter, increasing vulnerability to chemical and physical damage.

Vitiligo in Practice:​ Case-Based Approaches for Patient Care

Susan C. Taylor, MD, moderated a recent Case-Based Roundtable discussion on topical treatment options for vitiligo.

The Hassle Stops Here: Icotrokinra Takes Aim at Psoriasis Care Gaps

Only 15–20% of eligible patients currently receive systemic psoriasis treatment, and specialists believe icotrokinra's simplicity could meaningfully move that needle.

Derm Dispatch: The Modern Utility of Sodium Hypochlorite and Hypochlorous Acid Beyond the Bleach Bath

Renata Block, DMSc, MMS, PA-C, and Jamie Restivo, MPAS, PA-C, explore how hypochlorous acid sprays and sodium hypochlorite washes simplify AD adjunct care.